Literature DB >> 25421938

Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature.

M T Sartori, S M Teresa1, M Milan, M Marta, E de Bon, D B Emiliano, M Fadin, F Mariangela, R Pesavento, P Raffaele, E Zanon, Z Ezio.   

Abstract

Thrombotic events in congenital hypo-afibrinogenemia have been rarely reported, either in association or not with replacement therapy or thrombotic risk factors. We describe clinical findings and management of thrombosis of abdominal aorta with peripheral embolism in a patient with congenital afibrinogenemia. A review of arterial thrombosis in inherited hypo-afibrinogenemia was also performed. The patient with a severe bleeding history requiring prophylaxis with fibrinogen concentrates (FC) was admitted for ischaemia of the 4th right toe. An angio-CT of abdominal aorta showed a thrombosis from the origin of renal arteries to the carrefour with a distal floating part. No thrombotic risk factors were found; a previous traumatic lesion of aortic wall might have triggered the thrombus formation, whereas the role of FC prophylaxis remains uncertain. The patient was successfully treated with FC, enoxaparin followed by fondaparinux, and low-dose aspirin without bleeding or thrombosis recurrence. After 2 years, aortic thrombus was almost completely recovered. Sixteen hypo/afibrinogenemia patients with arterial thrombosis were found in Literature, showing that thrombosis often occurs at a young age, involves large vessels, its recurrence is not unusual, and therapeutic strategy is not defined yet. Our therapeutic approach was effective and also safe, but further studies are needed to improve the knowledge of pathogenesis and the anti-thrombotic management in this peculiar setting.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  afibrinogenemia; anticoagulant drugs; antiplatelet drugs; arterial thrombosis; hypofibrinogenemia; rare bleeding disorders

Mesh:

Year:  2014        PMID: 25421938     DOI: 10.1111/hae.12507

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

Review 1.  Thrombosis in Inherited Fibrinogen Disorders.

Authors:  Wolfgang Korte; Man-Chiu Poon; Alfonso Iorio; Michael Makris
Journal:  Transfus Med Hemother       Date:  2017-03-14       Impact factor: 3.747

2.  Treating a Patient of Dysfibrinogenemia with Acute Thromboembolism by Rivaroxaban and Cilostazol.

Authors:  Emre Ozker; Figen Atalay; Oyku Gulmez; Bulent Saritas
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-21       Impact factor: 0.900

3.  Thromboembolic events in patients with severe inherited fibrinogen deficiency.

Authors:  Amihai Rottenstreich; Avigal Lask; Lilliana Schliamser; Ariella Zivelin; Uri Seligsohn; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 4.  Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX).

Authors:  Antonio Girolami; Silvia Ferrari; Elisabetta Cosi; Claudia Santarossa; Maria Luigia Randi
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-14       Impact factor: 2.389

5.  Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria.

Authors:  Soraya Hadjali-Saichi; Philippe de Mazancourt; Jacqueline Tapon-Bretaudière; Tristan Mirault; Kahina Guenounou; Issam Frigaa; Anne-Marie Fischer; Ouerdia Chafa; Dominique Helley
Journal:  Haemophilia       Date:  2022-04-30       Impact factor: 4.263

6.  Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency.

Authors:  S Le Quellec; A Desjonqueres; L Rugeri; H Desmurs Clavel; F Farhat; L Mechtouff; Y Dargaud
Journal:  Thromb J       Date:  2018-04-04

7.  Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications.

Authors:  Daisuke Hiramatsu; Yoshito Ogihara; Takeshi Matsumoto; Kei Sato; Akihiro Takasaki; Tairo Kurita; Ryuji Okamoto; Hideo Wada; Kaoru Dohi
Journal:  Intern Med       Date:  2021-07-30       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.